trial

Positron Emission Tomography (PET) Study Investigating Dopamine and Serotonin Receptor Occupancy After Multiple Oral Dosing of Lu AF35700

NCTId NCT02333487
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 1 · Completed
Enrollment 22 (actual)
Sponsored by H. Lundbeck A/S
Primary completion 2016-02-11
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 1
Status
Completed
Enrollment
22 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2014-12-30
Primary completion
2016-02-11
Eligibility
MALE · 18 Years · 60 Years

Interventions & indications

Drugs
Lu AF35700

Sponsors

H. Lundbeck A/SLead Sponsor

Sites

1 total
Rockville, United States

Facts & assertions

4 sourced
Enrollment
22
Phase
PHASE1
Primary Completion Date
2016-02-11
Status
COMPLETED
relationships
The graph out of here
drug
Lu AF35700
drug
lead_sponsor
H. Lundbeck A/S
company
indication
Schizophrenia
indication
Schizophrenia
indication